Literature DB >> 28679756

Herpes Simplex Virus 1 Small Capsomere-Interacting Protein VP26 Regulates Nucleocapsid Maturation.

Ryosuke Kobayashi1,2, Akihisa Kato1,2, Hiroshi Sagara3, Mizuki Watanabe1,2, Yuhei Maruzuru1,2, Naoto Koyanagi1,2, Jun Arii1,2, Yasushi Kawaguchi4,2.   

Abstract

VP26 is a herpes simplex virus 1 (HSV-1) small capsomere-interacting protein. In this study, we investigated the function of VP26 in HSV-1-infected cells with the following results. (i) The VP26 null mutation significantly impaired incorporation of minor capsid protein UL25 into nucleocapsids (type C capsids) in the nucleus. (ii) The VP26 mutation caused improper localization of UL25 in discrete punctate domains containing multiple capsid proteins (e.g., the VP5 major capsid protein) in the nucleus; these domains corresponded to capsid aggregates. (iii) The VP26 mutation significantly impaired packaging of replicated viral DNA genomes into capsids but had no effect on viral DNA concatemer cleavage. (iv) The VP26 mutation reduced the frequency of type C capsids, which contain viral DNA but not scaffolding proteins, and produced an accumulation of type A capsids, which lack both viral DNA and scaffold proteins, and had no effect on accumulation of type B capsids, which lack viral DNA but retain cleaved scaffold proteins. Collectively, these results indicated that VP26 was required for efficient viral DNA packaging and proper localization of nuclear capsids. The phenotype of the VP26 null mutation was similar to that reported previously of the UL25 null mutation and of UL25 mutations that preclude UL25 binding to capsids. Thus, VP26 appeared to regulate nucleocapsid maturation by promoting incorporation of UL25 into capsids, which is likely to be required for proper capsid nuclear localization.IMPORTANCE HSV-1 VP26 has been reported to be important for viral replication and virulence in cell cultures and/or mouse models. However, little is known about the function of VP26 during HSV-1 replication, in particular, in viral nucleocapsid maturation although HSV-1 nucleocapsids are estimated to contain 900 copies of VP26. In this study, we present data suggesting that VP26 promoted packaging of HSV-1 DNA genomes into capsids by regulating incorporation of capsid protein UL25 into capsids, which was reported to increase stability of the capsid structure. We also showed that VP26 was required for proper localization of capsids in the infected cell nucleus. This is the first report showing that HSV-1 VP26 is a regulator for nucleocapsid maturation.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  HSV; VP26; nucleocapsid maturation

Mesh:

Substances:

Year:  2017        PMID: 28679756      PMCID: PMC5571263          DOI: 10.1128/JVI.01068-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Capsid assembly and DNA packaging in herpes simplex virus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-07       Impact factor: 6.989

2.  Role of the UL25 protein in herpes simplex virus DNA encapsidation.

Authors:  Shelley K Cockrell; Minerva E Sanchez; Angela Erazo; Fred L Homa
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

3.  Eclipse phase of herpes simplex virus type 1 infection: Efficient dynein-mediated capsid transport without the small capsid protein VP26.

Authors:  Katinka Döhner; Kerstin Radtke; Simone Schmidt; Beate Sodeik
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  A mutation in UL15 of herpes simplex virus 1 that reduces packaging of cleaved genomes.

Authors:  Kui Yang; Elizabeth G Wills; Joel D Baines
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0.

Authors:  Michiko Tanaka; Yukihiro Nishiyama; Tetsutaro Sata; Yasushi Kawaguchi
Journal:  Virology       Date:  2005-08-10       Impact factor: 3.616

6.  Herpes virus genome, the pressure is on.

Authors:  David W Bauer; Jamie B Huffman; Fred L Homa; Alex Evilevitch
Journal:  J Am Chem Soc       Date:  2013-07-23       Impact factor: 15.419

7.  Regulation of the catalytic activity of herpes simplex virus 1 protein kinase Us3 by autophosphorylation and its role in pathogenesis.

Authors:  Ken Sagou; Takahiko Imai; Hiroshi Sagara; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection.

Authors:  Vaishali Chaudhuri; Marvin Sommer; Jaya Rajamani; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids.

Authors:  Z H Zhou; J He; J Jakana; J D Tatman; F J Rixon; W Chiu
Journal:  Nat Struct Biol       Date:  1995-11

10.  Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids.

Authors:  Edward M Perkins; Daniel Anacker; Aaron Davis; Vishwam Sankar; Richard F Ambinder; Prashant Desai
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

View more
  7 in total

1.  Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.

Authors:  Daniel J J Carr; Grzegorz B Gmyrek; Adrian Filiberti; Amanda N Berube; William P Browne; Brett M Gudgel; Virginie H Sjoelund
Journal:  Immunohorizons       Date:  2020-10-09

2.  Identification of the Capsid Binding Site in the Herpes Simplex Virus 1 Nuclear Egress Complex and Its Role in Viral Primary Envelopment and Replication.

Authors:  Kosuke Takeshima; Jun Arii; Yuhei Maruzuru; Naoto Koyanagi; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 3.  Controlling the Revolving and Rotating Motion Direction of Asymmetric Hexameric Nanomotor by Arginine Finger and Channel Chirality.

Authors:  Peixuan Guo; Dana Driver; Zhengyi Zhao; Zhen Zheng; Chun Chan; Xiaolin Cheng
Journal:  ACS Nano       Date:  2019-05-28       Impact factor: 15.881

4.  Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines.

Authors:  Ifeanyi Kingsley Uche; Brent A Stanfield; Jared S Rudd; Konstantin G Kousoulas; Paul J F Rider
Journal:  Front Mol Biosci       Date:  2022-01-26

5.  An Attenuated HSV-1-Derived Malaria Vaccine Expressing Liver-Stage Exported Proteins Induces Sterilizing Protection against Infectious Sporozoite Challenge.

Authors:  Paul J F Rider; Mohd Kamil; Ilknur Yilmaz; Habibe N Atmaca; Merve Kalkan-Yazici; Mehmet Ziya Doymaz; Konstantin G Kousoulas; Ahmed S I Aly
Journal:  Vaccines (Basel)       Date:  2022-02-16

Review 6.  Experimental Dissection of the Lytic Replication Cycles of Herpes Simplex Viruses in vitro.

Authors:  Francisco J Ibáñez; Mónica A Farías; Maria P Gonzalez-Troncoso; Nicolás Corrales; Luisa F Duarte; Angello Retamal-Díaz; Pablo A González
Journal:  Front Microbiol       Date:  2018-10-11       Impact factor: 5.640

Review 7.  The Ins and Outs of Herpesviral Capsids: Divergent Structures and Assembly Mechanisms across the Three Subfamilies.

Authors:  Elizabeth B Draganova; Jonathan Valentin; Ekaterina E Heldwein
Journal:  Viruses       Date:  2021-09-23       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.